A Phase I Trial of a 3-Day Topotecan Q 21 Days for Recurrent Epithelial Cancers of the Ovary, Fallopian Tube, and Peritoneum

Author: Brown J.V.   Peters W.A.   Rettenmaier M.A.   Karlan B.Y.   Dillman R.A.   Smith M.R.   Drescher C.W.   Micha J.P.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.79, Iss.3, 2000-12, pp. : 495-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content